Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. lists 63 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 50458-588 | Concerta Tablet, Extended Release | Methylphenidate Hydrochloride 27 mg/1 | Rx |
| 50458-587 | Concerta Tablet, Extended Release | Methylphenidate Hydrochloride 54 mg/1 | Rx |
| 50458-586 | Concerta Tablet, Extended Release | Methylphenidate Hydrochloride 36 mg/1 | Rx |
| 50458-585 | Concerta Tablet, Extended Release | Methylphenidate Hydrochloride 18 mg/1 | Rx |
| 50458-098 | Elmiron Capsule, Gelatin Coated | Pentosan Polysulfate Sodium 100 mg/1 | Rx |
| 50458-554 | Invega Tablet, Extended Release | Paliperidone 1.5 mg/1 | Rx |
| 50458-552 | Invega Tablet, Extended Release | Paliperidone 9 mg/1 | Rx |
| 50458-551 | Invega Tablet, Extended Release | Paliperidone 6 mg/1 | Rx |
| 50458-550 | Invega Tablet, Extended Release | Paliperidone 3 mg/1 | Rx |
| 50458-612 | Invega Hafyera Injection, Suspension, Extended Release | Paliperidone Palmitate 1560 mg/5mL | Rx |
| 50458-611 | Invega Hafyera Injection, Suspension, Extended Release | Paliperidone Palmitate 1092 mg/3.5mL | Rx |
| 50458-563 | Invega Sustenna Injection | Paliperidone Palmitate 156 mg/mL | Rx |
| 50458-564 | Invega Sustenna Injection | Paliperidone Palmitate 234 mg/1.5mL | Rx |
| 50458-562 | Invega Sustenna Injection | Paliperidone Palmitate 117 mg/.75mL | Rx |
| 50458-561 | Invega Sustenna Injection | Paliperidone Palmitate 78 mg/.5mL | Rx |
| 50458-560 | Invega Sustenna Injection | Paliperidone Palmitate 39 mg/.25mL | Rx |
| 50458-606 | Invega Trinza Injection, Suspension, Extended Release | Paliperidone Palmitate 273 mg/.88mL | Rx |
| 50458-607 | Invega Trinza Injection, Suspension, Extended Release | Paliperidone Palmitate 410 mg/1.32mL | Rx |
| 50458-609 | Invega Trinza Injection, Suspension, Extended Release | Paliperidone Palmitate 819 mg/2.63mL | Rx |
| 50458-608 | Invega Trinza Injection, Suspension, Extended Release | Paliperidone Palmitate 546 mg/1.75mL | Rx |
| 50458-540 | Invokamet Tablet, Film Coated | Canagliflozin 50 mg/1; Metformin Hydrochloride 500 mg/1 | Rx |
| 50458-541 | Invokamet Tablet, Film Coated | Canagliflozin 50 mg/1; Metformin Hydrochloride 1000 mg/1 | Rx |
| 50458-542 | Invokamet Tablet, Film Coated | Canagliflozin 150 mg/1; Metformin Hydrochloride 500 mg/1 | Rx |
| 50458-543 | Invokamet Tablet, Film Coated | Canagliflozin 150 mg/1; Metformin Hydrochloride 1000 mg/1 | Rx |
| 50458-943 | Invokamet Xr Tablet, Film Coated, Extended Release | Canagliflozin 150 mg/1; Metformin Hydrochloride 1000 mg/1 | Rx |
| 50458-942 | Invokamet Xr Tablet, Film Coated, Extended Release | Canagliflozin 150 mg/1; Metformin Hydrochloride 500 mg/1 | Rx |
| 50458-941 | Invokamet Xr Tablet, Film Coated, Extended Release | Canagliflozin 50 mg/1; Metformin Hydrochloride 1000 mg/1 | Rx |
| 50458-940 | Invokamet Xr Tablet, Film Coated, Extended Release | Canagliflozin 50 mg/1; Metformin Hydrochloride 500 mg/1 | Rx |
| 50458-140 | Invokana Tablet, Film Coated | Canagliflozin 100 mg/1 | Rx |
| 50458-141 | Invokana Tablet, Film Coated | Canagliflozin 300 mg/1 | Rx |
| 50458-720 | Ponvory Tablet, Film Coated | Ponesimod 20 mg/1 | Rx |
| 50458-707 | Ponvory Kit | Rx | |
| 50458-305 | Risperdal Solution | Risperidone 1 mg/mL | Rx |
| 50458-300 | Risperdal Tablet | Risperidone 1 mg/1 | Rx |
| 50458-302 | Risperdal Tablet | Risperidone .5 mg/1 | Rx |
| 50458-350 | Risperdal Tablet | Risperidone 4 mg/1 | Rx |
| 50458-330 | Risperdal Tablet | Risperidone 3 mg/1 | Rx |
| 50458-320 | Risperdal Tablet | Risperidone 2 mg/1 | Rx |
| 50458-309 | Risperdal Consta Kit | Rx | |
| 50458-308 | Risperdal Consta Kit | Rx | |
| 50458-306 | Risperdal Consta Kit | Rx | |
| 50458-307 | Risperdal Consta Kit | Rx | |
| 50458-315 | Risperdal M-tab Tablet, Orally Disintegrating | Risperidone 1 mg/1 | Rx |
| 50458-355 | Risperdal M-tab Tablet, Orally Disintegrating | Risperidone 4 mg/1 | Rx |
| 50458-395 | Risperdal M-tab Tablet, Orally Disintegrating | Risperidone .5 mg/1 | Rx |
| 50458-325 | Risperdal M-tab Tablet, Orally Disintegrating | Risperidone 2 mg/1 | Rx |
| 50458-335 | Risperdal M-tab Tablet, Orally Disintegrating | Risperidone 3 mg/1 | Rx |
| 50458-596 | Risperidone Solution | Risperidone 1 mg/mL | Rx |
| 50458-290 | Sporanox Capsule | Itraconazole 100 mg/1 | Rx |
| 50458-028 | Spravato Solution | Esketamine Hydrochloride 28 mg/.2mL | Rx |
| 50458-645 | Topamax Capsule, Coated Pellets | Topiramate 25 mg/1 | Rx |
| 50458-647 | Topamax Capsule, Coated Pellets | Topiramate 15 mg/1 | Rx |
| 50458-642 | Topamax Tablet, Coated | Topiramate 200 mg/1 | Rx |
| 50458-641 | Topamax Tablet, Coated | Topiramate 100 mg/1 | Rx |
| 50458-640 | Topamax Tablet, Coated | Topiramate 50 mg/1 | Rx |
| 50458-639 | Topamax Tablet, Coated | Topiramate 25 mg/1 | Rx |
| 50458-675 | Vermox Tablet, Chewable | Mebendazole 500 mg/1 | Rx |
| 50458-575 | Xarelto Granule, For Suspension | Rivaroxaban 155 mg/1 | Rx |
| 50458-577 | Xarelto Tablet, Film Coated | Rivaroxaban 2.5 mg/1 | Rx |
| 50458-578 | Xarelto Tablet, Film Coated | Rivaroxaban 15 mg/1 | Rx |
| 50458-584 | Xarelto Kit | Rx | |
| 50458-580 | Xarelto Tablet, Film Coated | Rivaroxaban 10 mg/1 | Rx |
| 50458-579 | Xarelto Tablet, Film Coated | Rivaroxaban 20 mg/1 | Rx |
Recalls by Janssen Pharmaceuticals, Inc.
- D-0218-2019 Nov 14, 2018 · Class II
Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser. - D-0217-2019 Nov 14, 2018 · Class II
Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser. - D-1063-2015 May 20, 2015 · Class II
Subpotent Drug - D-1514-2014 Aug 13, 2014 · Class II
Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample